Fosfomycin (also known as phosphomycin or phosphonomycin and the trade names Monurol and Monuril) is a broad-spectrum antibiotic produced by certain Streptomyces species, although it can now be made by chemical synthesis.

Market Analysis and Insights: Global Fosfomycin Market
The global Fosfomycin market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Fosfomycin Scope and Market Size
The global Fosfomycin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fosfomycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Fosfomycin Calcium
Fosfomycin Sodium
Fosfomycin Trometamol

Segment by Application
Injection Drugs
Oral Drugs

The Fosfomycin market is analysed and market size information is provided by regions (countries). Segment by Application, the Fosfomycin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Northeast Pharm
Ercros
Shinpoong Pharm
Interquim
Manus Aktteva Biopharma LLP
Selectchemie
Hunan Huana Pharmaceuticals
Hubei Xunda Pharmaceutical Co.,Ltd.
Guilin Hwasun
FarmaSino Pharmaceutical